Prostate Carcinogenesis: Insights in Relation to Epigenetics and Inflammation.

Endocrine, Metabolic & Immune Disorders Drug Targets
Mirazkar D PandareeshKullaiah Byrappa

Abstract

Prostate cancer is a multifactorial disease that mainly occurs due to the accumulation of somatic, genetic, and epigenetic changes, resulting in the inactivation of tumor-suppressor genes and activation of oncogenes. Mutations in genes, specifically those that control cell growth and division or the repair of damaged DNA, make the cells grow and divide uncontrollably to form a tumor. The risk of developing prostate cancer depends upon the gene that has undergone the mutation. Identifying such genetic risk factors for prostate cancer poses a challenge for the researchers. Besides genetic mutations, many epigenetic alterations, including DNA methylation, histone modifications (methylation, acetylation, ubiquitylation, sumoylation, and phosphorylation) nucleosomal remodeling, and chromosomal looping, have significantly contributed to the onset of prostate cancer as well as the prognosis, diagnosis, and treatment of prostate cancer. Chronic inflammation also plays a major role in the onset and progression of human cancer, via modifications in the tumor microenvironment by initiating epithelialmesenchymal transition and remodeling the extracellular matrix. In this article, the authors present a brief history of the mechanisms and po...Continue Reading

Related Concepts

Related Papers

Frontiers in Bioscience : a Journal and Virtual Library
Long-Cheng Li
Translational Andrology and Urology
Vincenza ConteducaHimisha Beltran
Epigenomics
Marjolaine NgolloDominique J Bernard-Gallon
The Journal of Urology
Mark L Gonzalgo, W B Isaacs
Frontiers in Bioscience : a Journal and Virtual Library
William G NelsonAngelo M De Marzo
© 2021 Meta ULC. All rights reserved